Market Overview

Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14

Share:
Related BSX
Earnings Scheduled For July 23, 2015
Boston Scientific Initiates Study Evaluating New Fully Resorbable Scaffold Technology
Should You Buy Evolving Trends in Medical Devices? - Industry Outlook (Zacks)

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12^th.

Posted-In: News M&A

 

Related Articles (BSX)

Get Benzinga's Newsletters